Clinical and immunologic investigations in patients with stiff-person spectrum disorder

JAMA Neurology

Volumn 73, Issue 6, 2016, Pages 714-720

  Martinez Hernandez, Eugenia ^a,b   Ariño, Helena ^a,b   McKeon, Andrew ^c   Iizuka, Takahiro ^d   Titulaer, Maarten J ^e   Simabukuro, Mateus M ^f   Lancaster, Eric ^g   Petit Pedrol, Mar ^b   Planagumà, Jesú ^b   Blanco, Yolanda ^a   Harvey, Robert J ^h   Saiz, Albert ^a   Graus, Francesc ^a,b   Dalmau, Josep ^b,g,i  

^a UNIVERSITY OF BARCELONA   (Spain)

^b INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

^c MAYO CLINIC   (United States)

^d KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^e ERASMUS MEDICAL CENTER   (Netherlands)

^f UNIVERSITY OF SÃO PAULO   (Brazil)

^g UNIVERSITY OF PENNSYLVANIA   (United States)

^h UNIVERSITY OF LONDON   (United Kingdom)

ⁱ INSTITUCIÓ CATALANA DE RECERCA I ESTUDIS AVANÇATS ICREA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; 4 AMINOBUTYRIC ACID A RECEPTOR ANTIBODY; GEPHYRIN; GEPHYRIN ANTIBODY; GLUTAMATE DECARBOXYLASE 65 ANTIBODY; GLYCINE RECEPTOR; GLYCINE RECEPTOR ANTIBODY; PROTEIN ANTIBODY; UNCLASSIFIED DRUG; AUTOANTIBODY; GLUTAMATE DECARBOXYLASE;

ADULT; ANTIBODY DETECTION; ARTICLE; ATAXIA; AUTOIMMUNITY; CLINICAL FEATURE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE SEVERITY; ENCEPHALITIS; EPILEPSY; FEMALE; HUMAN; IMMUNOLOGY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RETROSPECTIVE STUDY; STIFF LIMB SYNDROME; STIFF MAN SYNDROME; STIFF PERSON SPECTRUM DISORDER; BLOOD; CEREBROSPINAL FLUID; MIDDLE AGED; SEVERITY OF ILLNESS INDEX;

ADULT; AUTOANTIBODIES; AUTOIMMUNITY; COHORT STUDIES; FEMALE; GLUTAMATE DECARBOXYLASE; HUMANS; MALE; MIDDLE AGED; RECEPTORS, GLYCINE; SEVERITY OF ILLNESS INDEX; STIFF-PERSON SYNDROME;

EID: 84974627327     PISSN: 21686149     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamaneurol.2016.0133     Document Type: Article

References (37)

1. Lorish TR, Thorsteinsson G, Howard FM Jr. Stiff-man syndrome updated. Mayo Clin Proc. 1989; 64(6):629-636.
2. Toro C, Jacobowitz DM, Hallett M. Stiff-man syndrome. Semin Neurol. 1994;14(2):154-158.
3. Meinck HM, Ricker K, Hülser PJ, Schmid E, Peiffer J, Solimena M. Stiff man syndrome: clinical and laboratory findings in eight patients. J Neurol. 1994;241(3):157-166.
4. Brown P, Rothwell JC, Marsden CD. The stiff leg syndrome. J Neurol Neurosurg Psychiatry. 1997;62 (1):31-37.
5. Saiz A, Graus F, Valldeoriola F, Valls-SoléJ, Tolosa E. Stiff-leg syndrome: a focal form of stiff-man syndrome. Ann Neurol. 1998;43(3):400-403.
6. Barker RA, Revesz T, Thom M, Marsden CD, Brown P. Review of 23 patients affected by the stiff man syndrome: clinical subdivision into stiff trunk (man) syndrome, stiff limb syndrome, and progressive encephalomyelitis with rigidity. J Neurol Neurosurg Psychiatry. 1998;65(5):633-640.
7. Solimena M, Folli F, Aparisi R, Pozza G, De Camilli P. Autoantibodies to GABA-ergic neurons and pancreatic β cells in stiff-man syndrome. N Engl JMed. 1990;322(22):1555-1560.
8. Solimena M, De Camilli P. Autoimmunity to glutamic acid decarboxylase (GAD) in stiff-man syndrome and insulin-dependent diabetes mellitus. Trends Neurosci. 1991;14(10):452-457.
9. Hutchinson M,Waters P, McHugh J, et al. Progressive encephalomyelitis, rigidity, and myoclonus: a novel glycine receptor antibody. Neurology. 2008;71(16):1291-1292.
10. Mas N, Saiz A, Leite MI, et al. Antiglycine-receptor encephalomyelitis with rigidity. J Neurol Neurosurg Psychiatry. 2011;82(12):1399-1401.
11. De Camilli P, Thomas A, Cofiell R, et al. The synaptic vesicle-associated protein amphiphysin is the 128-kD autoantigen of stiff-man syndrome with breast cancer. J Exp Med. 1993;178(6):2219-2223.
12. Butler MH, Hayashi A, Ohkoshi N, et al. Autoimmunity to gephyrin in stiff-man syndrome. Neuron. 2000;26(2):307-312.
13. Boronat A, Gelfand JM, Gresa-Arribas N, et al. Encephalitis and antibodies to dipeptidyl-peptidase-like protein-6, a subunit of Kv4.2 potassium channels. Ann Neurol. 2013;73(1): 120-128.
14. Balint B, Jarius S, Nagel S, et al. Progressive encephalomyelitis with rigidity andmyoclonus: a new variant with DPPX antibodies. Neurology. 2014;82(17):1521-1528.
15. Petit-Pedrol M, Armangue T, Peng X, et al. Encephalitis with refractory seizures, status epilepticus, and antibodies to the GABAA receptor: a case series, characterisation of the antigen, and analysis of the effects of antibodies. Lancet Neurol. 2014;13(3):276-286.
16. Baizabal-Carvallo JF, Jankovic J. Stiff-person syndrome: insights into a complex autoimmune disorder. J Neurol Neurosurg Psychiatry. 2015;86 (8):840-848.
17. Honnorat J, Saiz A, Giometto B, et al. Cerebellar ataxia with anti-glutamic acid decarboxylase antibodies: study of 14 patients. Arch Neurol. 2001; 58(2):225-230.
18. Peltola J, Kulmala P, Isojärvi J, et al. Autoantibodies to glutamic acid decarboxylase in patients with therapy-resistant epilepsy. Neurology. 2000;55(1):46-50.
19. MalterMP, Helmstaedter C, Urbach H, Vincent A, Bien CG. Antibodies to glutamic acid decarboxylase define a form of limbic encephalitis. Ann Neurol. 2010;67(4):470-478.
20. Saiz A, Blanco Y, Sabater L, et al. Spectrum of neurological syndromes associated with glutamic acid decarboxylase antibodies: diagnostic clues for this association. Brain. 2008;131(pt 10):2553-2563.
21. Banks JL, Marotta CA. Outcomes validity and reliability of the modified Rankin scale: implications for stroke clinical trials: a literature review and synthesis. Stroke. 2007;38(3):1091-1096.
22. Levy LM, Dalakas MC, Floeter MK. The stiff-person syndrome: an autoimmune disorder affecting neurotransmission of gamma-aminobutyric acid. Ann Intern Med. 1999;131(7):522-530.
23. Dalakas MC, Fujii M, Li M, McElroy B. The clinical spectrum of anti-GAD antibody-positive patients with stiff-person syndrome. Neurology. 2000;55(10):1531-1535.
24. Meinck HM, Thompson PD. Stiff man syndrome and related conditions. Mov Disord. 2002;17(5): 853-866.
25. Davies JS, Chung S-K, Thomas RH, et al. The glycinergic system in human startle disease: a genetic screening approach. Front Mol Neurosci. 2010;3:8.
26. McKeon A, Robinson MT, McEvoy KM, et al. Stiff-man syndrome and variants: clinical course, treatments, and outcomes. Arch Neurol. 2012;69 (2):230-238.
27. Pittock SJ, Lucchinetti CF, Parisi JE, et al. Amphiphysin autoimmunity: paraneoplastic accompaniments. Ann Neurol. 2005;58(1):96-107.
28. Dropcho EJ. Antiamphiphysin antibodies with small-cell lung carcinoma and paraneoplastic encephalomyelitis. Ann Neurol. 1996;39(5):659-667.
29. Ariño H, Gresa-Arribas N, Blanco Y, et al. Cerebellar ataxia and glutamic acid decarboxylase antibodies: immunologic profile and long-term effect of immunotherapy. JAMA Neurol. 2014;71(8): 1009-1016.
30. Martinez-Hernandez E, Sepulveda M, Rostásy K, et al. Antibodies to aquaporin 4, myelin-oligodendrocyte glycoprotein, and the glycine receptor α1 subunit in patients with isolated optic neuritis. JAMA Neurol. 2015;72(2):187-193.
31. Gresa-Arribas N, Ariño H, Martínez-Hernández E, et al. Antibodies to inhibitory synaptic proteins in neurological syndromes associated with glutamic acid decarboxylase autoimmunity. PLoS One. 2015; 10(3):e0121364.
32. McKeon A, Martinez-Hernandez E, Lancaster E, et al. Glycine receptor autoimmune spectrum with stiff-man syndrome phenotype. JAMA Neurol. 2013; 70(1):44-50.
33. Alexopoulos H, Akrivou S, Dalakas MC. Glycine receptor antibodies in stiff-person syndrome and other GAD-positive CNS disorders. Neurology. 2013;81(22):1962-1964.
34. Carvajal-González A, Leite MI,Waters P, et al. Glycine receptor antibodies in PERM and related syndromes: characteristics, clinical features and outcomes [published correction appears in Brain. 201413(pt, 12):3315].
35. Brain. 2014;137(pt 8):2178-2192.
36. Brown P, Marsden CD. The stiff man and stiff man plus syndromes. J Neurol. 1999;246(8):648-652.
37. TobinWO, Lennon VA, Komorowski L, et al. DPPX potassium channel antibody: frequency, clinical accompaniments, and outcomes in 20 patients. Neurology. 2014;83(20):1797-1803.